NDONOVO THERAPEUTICS (ENDV) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 6 124 sessions, October 1, 2025 to October 1, 2026
- Largest daily move
- +100% close of October 3, 2025
- 1-year change
- +0% closing prices, October 1, 2025 to October 1, 2026
- 1-month change
- +0% closing prices, September 1, 2026 to October 1, 2026
Company Description
NDONOVO THERAPEUTICS (OTC: ENDV) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $144.6K.
ENDV has gained 0.0% over the past year. The last closing price was $0.0001.
For FY2022, NDONOVO THERAPEUTICS reported revenue of $135K.
This page collects what Stock Titan holds for ENDV, including price data, latest news, and financial highlights.
Stock Performance
NDONOVO THERAPEUTICS (ENDV) closed at $0.0001 on October 1, 2026. Over the past 12 months, the price has gained 0.0%.
ENDV Metrics & Rankings
Price returns through October 1, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NDONOVO THERAPEUTICS has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include fda approval, clinical trial, partnership. View all ENDV news →
SEC Filings
Financial Highlights
NDONOVO THERAPEUTICS generated $135K in revenue in FY2022, retaining a 92.6% gross margin, and operating income reached -$3.3M (-2411.7% operating margin). The company generated -$679K in operating cash flow. The current ratio was 0.00, measuring current assets divided by current liabilities.
Upcoming Events
ENDV Company Profile & Sector Positioning
NDONOVO THERAPEUTICS (ENDV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ENDV often look at related companies in the same sector, including GLOBESTAR THERAPEUTICS CO (GSTC), TRACON PHARMS INC (TCON), TREVENA INC (TRVN), SCORPIUS HOLDINGS INC (SCPX), and VINCERX PHARMA INC (VINC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENDV's relative position within its industry.